Matthew Angel

Insider Reports History

Entity
Individual
Location
10531 4 S Commons Drive, Suite 160 550, San Diego, CA
Signature
/s/ Matthew Angel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Angel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eterna Therapeutics Inc. President and CEO, Director Stock Option (right to buy) 132K Jan 12, 2023 Direct

Insider Reports Filed by Matthew Angel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ERNA Eterna Therapeutics Inc. Jan 12, 2023 1 $0 4 Jan 13, 2023 President and CEO, Director
ERNA Brooklyn ImmunoTherapeutics, Inc. Aug 1, 2022 1 $0 4 Aug 3, 2022 Interim President and CEO, Director
ERNA Brooklyn ImmunoTherapeutics, Inc. May 26, 2022 0 $0 3 Jun 1, 2022 Interim President and CEO